BioNTech in licensing deal with Chinese pharma Doer Biologics
香樟树下采金瓜
复星就是个笑话
照完镜子正衣冠
道尔是复星系列？
照完镜子正衣冠
an undisclosed target. Terms call for Doer to receive an upfront payment -- which was not disclosed -- as well as potential milestone payments.
照完镜子正衣冠
Doer focuses on the discovery of protein drugs for metabolic diseases and cancers. It has two candidates in the clinic, both in phase 1. One is for solid tumors, and the other for non-alcoholic steatohepatitis (NASH) and diabetes.
照完镜子正衣冠
BioNTech in licensing deal with Chinese pharma Doer Biologics
香樟树下采金瓜
复星就是个笑话
照完镜子正衣冠
道尔是复星系列？
照完镜子正衣冠
an undisclosed target. Terms call for Doer to receive an upfront payment -- which was not disclosed -- as well as potential milestone payments.
照完镜子正衣冠
Doer focuses on the discovery of protein drugs for metabolic diseases and cancers. It has two candidates in the clinic, both in phase 1. One is for solid tumors, and the other for non-alcoholic steatohepatitis (NASH) and diabetes.